- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Optimer Pharmaceuticals Inc
+ Add to WatchlistOPTR:US
14.6700 USD 0.2900 2.02%As of 17:20:00 ET on 05/23/2013.
Company Profile for Optimer Pharmaceuticals Inc (OPTR)
Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.
Contact Information
Optimer Pharmaceuticals Inc
101 Hudson Street
Suite 3501
Jersey City, NJ 07302
United States
Phone: 1-201-333-8819
Key Executives for Optimer Pharmaceuticals Inc (OPTR)
| Henry A McKinnell JrChairman/CEO | Stephen W WebsterChief Financial Officer |
| Eric SirotaChief Operating Officer | Meredith SchaumChief Compliance Ofcr/Gen Cnsl |
| Sherwood L GorbachSenior VP/Chief Scientific Ofcr | Linda E AmperSenior VP:Human Resources |
| David A WalseyVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page